Literature DB >> 21206093

Rationale for inhibition of the hedgehog pathway paracrine loop in pancreatic adenocarcinoma.

Anastasios Dimou, Kostas Syrigos, Muhammad Wasif Saif.   

Abstract

The role of hedgehog pathway in the biology of pancreatic adenocarcinoma is an emerging area of investigation and provides a novel field for treatment intervention. Recent studies have shown the activation of the hedgehog pathway in pancreatic cancer. Despite the initial assumption of an autocrine mechanism, it seems that the hedgehog pathway contributes to the molecular conversation between tumor and its microenvironment through a paracrine loop. Furthermore, members of the hedgehog pathway crosstalk with other pathways; they regulate tumor angiogenesis and are associated with cancer stem cells. In addition, there is preclinical evidence about the efficiency of hedgehog inhibitors both in vitro and in vivo and the first clinical trials with those compounds in the treatment of patients with pancreatic adenocarcinoma, are already under way.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21206093

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


  3 in total

1.  The matricellular protein CCN1/Cyr61 is a critical regulator of Sonic Hedgehog in pancreatic carcinogenesis.

Authors:  Inamul Haque; Archana De; Monami Majumder; Smita Mehta; Douglas McGregor; Sushanta K Banerjee; Peter Van Veldhuizen; Snigdha Banerjee
Journal:  J Biol Chem       Date:  2012-10-01       Impact factor: 5.157

2.  From Screening to Treatment of Pancreatic Cancer: A Comprehensive Review.

Authors:  Muhammad Wasif Saif
Journal:  JOP       Date:  2021-05-31

3.  Oncogenic Functions of Gli1 in Pancreatic Adenocarcinoma Are Supported by Its PRMT1-Mediated Methylation.

Authors:  Yan Wang; Jung-Mao Hsu; Ya'an Kang; Yongkun Wei; Pei-Chih Lee; Shing-Jyh Chang; Yi-Hsin Hsu; Jennifer L Hsu; Hung-Ling Wang; Wei-Chao Chang; Chia-Wei Li; Hsin-Wei Liao; Shih-Shin Chang; Weiya Xia; How-Wen Ko; Chao-Kai Chou; Jason B Fleming; Huamin Wang; Rosa F Hwang; Yue Chen; Jun Qin; Mien-Chie Hung
Journal:  Cancer Res       Date:  2016-10-06       Impact factor: 12.701

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.